Uridine treatment prevents myocardial injury in rat models of acute ischemia and ischemia/reperfusion by activating the mitochondrial ATP-dependent potassium channel

Abstract The effect of uridine on the myocardial ischemic and reperfusion injury was investigated. A possible mechanism of its cardioprotective action was established. Two rat models were used: (1) acute myocardial ischemia induced by occlusion of the left coronary artery for 60 min; and (2) myocard...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Irina B. Krylova, Elena N. Selina, Valentina V. Bulion, Olga M. Rodionova, Natalia R. Evdokimova, Natalia V. Belosludtseva, Maria I. Shigaeva, Galina D. Mironova
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/91dce8832b204e19896e31278e998607
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:91dce8832b204e19896e31278e998607
record_format dspace
spelling oai:doaj.org-article:91dce8832b204e19896e31278e9986072021-12-02T16:45:47ZUridine treatment prevents myocardial injury in rat models of acute ischemia and ischemia/reperfusion by activating the mitochondrial ATP-dependent potassium channel10.1038/s41598-021-96562-72045-2322https://doaj.org/article/91dce8832b204e19896e31278e9986072021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-96562-7https://doaj.org/toc/2045-2322Abstract The effect of uridine on the myocardial ischemic and reperfusion injury was investigated. A possible mechanism of its cardioprotective action was established. Two rat models were used: (1) acute myocardial ischemia induced by occlusion of the left coronary artery for 60 min; and (2) myocardial ischemia/reperfusion with 30-min ischemia and 120-min reperfusion. In both models, treatment with uridine (30 mg/kg) prevented a decrease in cell energy supply and in the activity of the antioxidant system, as well as an increase in the level of lipid hydroperoxides and diene conjugates. This led to a reduction of the necrosis zone in the myocardium and disturbances in the heart rhythm. The blocker of the mitochondrial ATP-dependent potassium (mitoKATP) channel 5-hydroxydecanoate limited the positive effects of uridine. The data indicate that the cardioprotective action of uridine may be related to the activation of the mitoKATP channel. Intravenously injected uridine was more rapidly eliminated from the blood in hypoxia than in normoxia, and the level of the mitoKATP channel activator UDP in the myocardium after uridine administration increased. The results suggest that the use of uridine can be a potentially effective approach to the management of cardiovascular diseases.Irina B. KrylovaElena N. SelinaValentina V. BulionOlga M. RodionovaNatalia R. EvdokimovaNatalia V. BelosludtsevaMaria I. ShigaevaGalina D. MironovaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Irina B. Krylova
Elena N. Selina
Valentina V. Bulion
Olga M. Rodionova
Natalia R. Evdokimova
Natalia V. Belosludtseva
Maria I. Shigaeva
Galina D. Mironova
Uridine treatment prevents myocardial injury in rat models of acute ischemia and ischemia/reperfusion by activating the mitochondrial ATP-dependent potassium channel
description Abstract The effect of uridine on the myocardial ischemic and reperfusion injury was investigated. A possible mechanism of its cardioprotective action was established. Two rat models were used: (1) acute myocardial ischemia induced by occlusion of the left coronary artery for 60 min; and (2) myocardial ischemia/reperfusion with 30-min ischemia and 120-min reperfusion. In both models, treatment with uridine (30 mg/kg) prevented a decrease in cell energy supply and in the activity of the antioxidant system, as well as an increase in the level of lipid hydroperoxides and diene conjugates. This led to a reduction of the necrosis zone in the myocardium and disturbances in the heart rhythm. The blocker of the mitochondrial ATP-dependent potassium (mitoKATP) channel 5-hydroxydecanoate limited the positive effects of uridine. The data indicate that the cardioprotective action of uridine may be related to the activation of the mitoKATP channel. Intravenously injected uridine was more rapidly eliminated from the blood in hypoxia than in normoxia, and the level of the mitoKATP channel activator UDP in the myocardium after uridine administration increased. The results suggest that the use of uridine can be a potentially effective approach to the management of cardiovascular diseases.
format article
author Irina B. Krylova
Elena N. Selina
Valentina V. Bulion
Olga M. Rodionova
Natalia R. Evdokimova
Natalia V. Belosludtseva
Maria I. Shigaeva
Galina D. Mironova
author_facet Irina B. Krylova
Elena N. Selina
Valentina V. Bulion
Olga M. Rodionova
Natalia R. Evdokimova
Natalia V. Belosludtseva
Maria I. Shigaeva
Galina D. Mironova
author_sort Irina B. Krylova
title Uridine treatment prevents myocardial injury in rat models of acute ischemia and ischemia/reperfusion by activating the mitochondrial ATP-dependent potassium channel
title_short Uridine treatment prevents myocardial injury in rat models of acute ischemia and ischemia/reperfusion by activating the mitochondrial ATP-dependent potassium channel
title_full Uridine treatment prevents myocardial injury in rat models of acute ischemia and ischemia/reperfusion by activating the mitochondrial ATP-dependent potassium channel
title_fullStr Uridine treatment prevents myocardial injury in rat models of acute ischemia and ischemia/reperfusion by activating the mitochondrial ATP-dependent potassium channel
title_full_unstemmed Uridine treatment prevents myocardial injury in rat models of acute ischemia and ischemia/reperfusion by activating the mitochondrial ATP-dependent potassium channel
title_sort uridine treatment prevents myocardial injury in rat models of acute ischemia and ischemia/reperfusion by activating the mitochondrial atp-dependent potassium channel
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/91dce8832b204e19896e31278e998607
work_keys_str_mv AT irinabkrylova uridinetreatmentpreventsmyocardialinjuryinratmodelsofacuteischemiaandischemiareperfusionbyactivatingthemitochondrialatpdependentpotassiumchannel
AT elenanselina uridinetreatmentpreventsmyocardialinjuryinratmodelsofacuteischemiaandischemiareperfusionbyactivatingthemitochondrialatpdependentpotassiumchannel
AT valentinavbulion uridinetreatmentpreventsmyocardialinjuryinratmodelsofacuteischemiaandischemiareperfusionbyactivatingthemitochondrialatpdependentpotassiumchannel
AT olgamrodionova uridinetreatmentpreventsmyocardialinjuryinratmodelsofacuteischemiaandischemiareperfusionbyactivatingthemitochondrialatpdependentpotassiumchannel
AT nataliarevdokimova uridinetreatmentpreventsmyocardialinjuryinratmodelsofacuteischemiaandischemiareperfusionbyactivatingthemitochondrialatpdependentpotassiumchannel
AT nataliavbelosludtseva uridinetreatmentpreventsmyocardialinjuryinratmodelsofacuteischemiaandischemiareperfusionbyactivatingthemitochondrialatpdependentpotassiumchannel
AT mariaishigaeva uridinetreatmentpreventsmyocardialinjuryinratmodelsofacuteischemiaandischemiareperfusionbyactivatingthemitochondrialatpdependentpotassiumchannel
AT galinadmironova uridinetreatmentpreventsmyocardialinjuryinratmodelsofacuteischemiaandischemiareperfusionbyactivatingthemitochondrialatpdependentpotassiumchannel
_version_ 1718383466074079232